Clinical Trial Update: Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing PET-CT tracers C-11 choline and 18F-fluoromethylcholine in metastatic prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Fluoromethylcholine (18F-fluoromethylcholine)
• C-11 Choline (Carbon-11 choline)

Snippet

Sponsor: Cancer Research UK | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN